The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-

Autor: McLeod, C., Dymock, M., Flanagan, K.L., Plebanski, M., Marshall, H., Estcourt, M.J., Tjiam, M.C., Blyth, C.C., Subbarao, K., Mordant, F.L., Nicholson, S., Faust, S.N., Wadia, U., Thornton, R.B., Ellis, Z., Mckenzie, A., Marsh, J.A., Snelling, T.L., Richmond, P.
Zdroj: In Journal of Infection December 2024 89(6)
Databáze: ScienceDirect
Externí odkaz: